A study on the clinical features of Oligometastasis in extensive stage small cell lung cancer.

A study on the clinical features of Oligometastasis in extensive stage small cell lung cancer. - HOT2301

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053402

Enrollment

250

Registered

2024-02-10

Start date

2023-06-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients with pathologically diagnosed small cell lung cancer (Neuro endocrine carcinoma (NEC) is excluded). (2) Patients aged 20 years or over at the time of obtaining consent. (iii) Patients receiving ICI+platinum combination chemotherapy as initial treatment, or as 1st line treatment after chemoradiotherapy for LD-SCLC or after relapse following radical surgery. (iv) No refusal of participation in this study by the research subjects themselves or by a person who is considered to be able to represent the will of the research subjects.

Exclusion criteria

Exclusion criteria: (1) Patients who underwent surgery prior to induction of first-line chemotherapy and received ICI + platinum combination therapy as adjuvant therapy. (2) Patients who are judged to be inappropriate as research subjects by the principal investigator.

Design outcomes

Primary

Measure	Time frame
Frequency of synchronous oligometastasis and origoprogression in small cell lung cancer.	—

Countries

Japan

Contacts

Public ContactKana Hashimoto

Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital Department of Thoracic Oncology and Respiratory Medicine

kana.hashimo@gmail.com03-3823-4890

Outcome results